Anti-osteoporosis agent-8
Product Specifications
Target
RANKL/RANK, NF-κB, p38 MAPK
Related Pathways
MAPK, NF-κB
Bioactivity
Anti-osteoporosis agent-8 (Compound 4aa) is a RANKL inhibitor, capable of preventing RANKL-induced osteoclastogenesis and osteoclast differentiation, with an IC50 of 2.41 μM. Furthermore, Anti-osteoporosis agent-8 has been shown to mitigate bone loss in an ovariectomized (OVX) mouse model.
Molecular Formula
C18H19F3N2O2Se
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP9C23-01 1 mg
Recombinant Swine Capsid Protein (Cap), N-His-SUMO and C-Myc
Sign In for Pricing
View Details AP9C23-02 100 µg
Recombinant Swine Capsid Protein (Cap), N-His-SUMO and C-Myc
Sign In for Pricing
View Details AP9C23-03 20 µg
Recombinant Swine Capsid Protein (Cap), N-His-SUMO and C-Myc
Sign In for Pricing
View Details 
EG3845-1 96 Well
Human Gastric Inhibitory Polypeptide (GIP) AssayMax™ ELISA Kit
Sign In for Pricing
View Details 